Other
Gastric Bypass Surgery
0
Pipeline Programs↗
1
Active Trials↗
0
Companies Involved↗
Gastric Bypass Surgery is an early-stage landscape with 0 programs across 0 companies.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
17
clinical trials
Completed12 · 71%
Unknown status2 · 12%
Withdrawn1 · 6%
Recruiting1 · 6%
Terminated1 · 6%
Clinical Trials
Trial Activity
17 trials
Intraoperative Lidocaine Infusion as a Sole Analgesic Versus Morphine in Laparoscopic Gastric Bypass Surgery
Completed·—·Phase 1·NCT05150756·60 enrolled
Determinants of Diabetes Remission After Gastric Bypass Surgery
Completed·—·Phase 1·NCT02287285·25 enrolled
Rivaroxaban Effects in Subjects Who Have Undergone Gastric Bypass Surgery
Terminated·SState University of New York - Upstate Medical University·Phase 1·NCT02058199·2 enrolled
Page 1 of 2
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)